Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH
« Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024)
Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) »
Aug 21
Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa
Categories:
Antimicrobial, Berthiaume Institute for Precision Health, Controlled release, Uncategorized
by Prakash
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery November 20, 2024Notice NOT-AI-24-072 from the NIH Guide for Grants and Contracts
- Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) November 20, 2024Funding Opportunity PAR-25-217 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) Tackling Acquisition of Language in Kids (TALK) initiative seeks to support activities to better understand early language learning and delay. NIH TALK invites applications for research projects that aim to better understand the information and practice needs of […]
- Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) November 20, 2024Funding Opportunity PAR-25-220 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research projects that aim to further understanding of the developmental trajectories of late talking children by leveraging existing data and creating open and shared data resources to aid in identifying patterns and […]
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) November 20, 2024Funding Opportunity RFA-DA-26-034 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or […]
- Occupational Safety and Health Training Project Grants [T03] November 20, 2024Funding Opportunity RFA-OH-25-003 from the NIH Guide for Grants and Contracts. The purpose of this announcement is to invite grant applications for Training Project Grants that are focused on occupational safety and health training.
- Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity November 20, 2024Notice NOT-AI-24-078 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity", NOT-AI-21-072 November 20, 2024Notice NOT-AI-25-001 from the NIH Guide for Grants and Contracts
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) November 20, 2024Funding Opportunity PAR-25-135 from the NIH Guide for Grants and Contracts. The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide […]
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery", NOT-AI-22-014 November 20, 2024Notice NOT-AI-24-086 from the NIH Guide for Grants and Contracts
- Notice of Participation of OBSSR in RFA-MH-26-140 "BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)" November 20, 2024Notice NOT-OD-25-034 from the NIH Guide for Grants and Contracts
Recent Comments